One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern ...

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...

People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...

A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales ...

The product is viewed by the CPG giant as a “one-of-a-kind opportunity” to help consumers rebuild or maintain muscle they ...

Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...

GLP-1 Drugs: Demand Surges in a Long-Established Market The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research.